SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute

MT Newswires Live

08/13

SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.

Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.

The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.

SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.

The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2559679771"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559679771\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559679771?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-13 13:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559679771","market":"sh","top_or_hot":-1,"title":"SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute","media":"MT Newswires Live","content":"<html><body><p> SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.</p><p>Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.</p><p>The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.</p><p>SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.</p><p>The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-13 13:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.</p><p>Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.</p><p>The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.</p><p>SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.</p><p>The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03681","symbol_name":"中国抗体-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2559679771","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559679771","pubTimestamp":1755061672,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SinoMab BioScience  has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03681":"中国抗体-B","BK1161":"生物科技","BK1574":"生物医药B类股"},"translate_title":"SinoMab与香港研究所签署为期3年的生物医药研发协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03681":0.9},"content_text":"SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}